Drug Development

FDA Approves Antibiotic to Treat Drug-Resistant Infections

Published in Medical Letter on the CDC and FDA, May 9th, 2000

Physicians are getting an important new weapon in the growing battle against drug-resistant infections: the U.S. government approved a long-awaited drug called Zyvox, described as the world's first entirely new type of antibiotic in 35 years.

Zyvox seems to cure some infections impervious to all other antibiotics, even that longtime drug of last resort called vancomycin. Consequently, Zyvox could help prevent hundreds, perhaps even thousands, of life-threatening infections every year.

"It comes at a time when we were literally running out of antibiotics," said Dr. Robert C. Moellering Jr., Beth Israel-Deaconness Hospital, Boston,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-05-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry